Legend Capital

Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.

DK Medtech, founded in 2015 and headquartered in Suzhou, China, specializes in the development and production of balloon catheter medical devices. The company is recognized as a leader in the medical device industry, focusing on innovative technologies that aim to meet the evolving challenges in healthcare. Through its commitment to excellence, DK Medtech strives to create impactful solutions that enhance patient care and improve medical outcomes.

Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.

Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.

Ligatech Bioscience, established in 2014 and headquartered in Qingpu, China, specializes in the design, development, production, and sales of medical devices for orthopedic and sports medicine. Its product portfolio includes molecular weight polyethylene suture and striped titanium plates, along with artificial ligaments and fixation systems. The company also offers technical advice and services to its users.

Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.

Tripod Preclinical Research is a Contract Research Organization that specializes in providing preclinical research services to the biopharmaceutical and medical device industries. The company offers a comprehensive range of services, including drug safety evaluation for new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Tripod's expertise encompasses non-human primate disease models, pharmacological efficacy studies, early drug evaluation, and Good Laboratory Practices (GLP) toxicology. Additionally, the organization supports translational medicine and clinical trials, along with biological analysis and the management of biological sample banks. By delivering these services, Tripod aids drug developers and researchers in advancing their projects through the critical early stages of research and development.

Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Sifli Technologies specializes in the design and development of chips for embedded artificial intelligence and Internet of Things (IoT) applications. The company creates platforms that facilitate data collection and processing for IoT sensors, as well as inferential processing for edge artificial intelligence. Its products support a range of applications, including smart wearables, medical and health equipment, home automation, intelligent terminals, industrial instruments, and intelligent buildings. By focusing on these areas, Sifli Technologies aims to enhance the functionality and efficiency of connected devices across various industries.

Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.

VectorBuilder is an online platform specializing in vector cloning and gene delivery solutions, catering to a range of needs from basic scientific research to clinical applications. The platform enables researchers to design and order custom gene delivery vectors efficiently, streamlining the process of vector construction and production. VectorBuilder offers a comprehensive suite of services, including vector customization, virus packaging, and advanced capabilities in adeno-associated virus capsid engineering. Additionally, the company provides Contract Research Organization (CRO) services and operates state-of-the-art facilities compliant with Good Manufacturing Practices (GMP), ensuring high-quality gene delivery tools for life sciences research and drug development.

Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

ClinChoice Kunling was established in Tianjin inSince its establishment, through its own organic growth and strategic mergers and acquisitions, ClinChoice has more than 3,000 clinical R&D professionals around the world, located in hot cities and regions of domestic and foreign pharmaceutical R&D, and has developed into a local clinical CRO enterprise model supporting innovative drug device R&D. . The company adheres to the connotation of "Kunxing Zhiyuan · Ling creates the future", which means to become an ideal partner for the clinical research and development of innovative pharmaceutical devices.

Reliable Med is a developer and provider of clinical mass spectrometry equipment designed for in vitro diagnostic (IVD) tests. The company focuses on addressing the needs of the medical industry by offering high-end clinical mass spectrometry devices and IVD detection kits. By doing so, Reliable Med aims to enhance the efficiency and accuracy of patient diagnoses within the healthcare sector.

Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Sailner 3D Technology specializes in the development and sale of industrial-grade 3D printers, focusing on color and multi-material printing capabilities. The company's innovative WJP white ink filling technology enables voxel-level precision, allowing for the creation of detailed and customizable products. Sailner's 3D printing solutions find applications in various sectors, including digital medical education, surgical planning, and industrial design, as well as in the production of high-precision jewelry models. Through its commitment to research and development, Sailner aims to enhance additive manufacturing technology and provide tailored applications to meet diverse industrial needs.

ForQaly specializes in the development of minimally invasive ventricular assist devices designed to treat heart failure patients. The company focuses on creating therapeutic devices that enhance circulation while ensuring affordability for patients. Their products are characterized by features such as reduced trauma, high auxiliary flow, and user-friendly design, providing healthcare professionals with effective solutions for improving patient health. By combining innovation with accessibility, ForQaly aims to address the clinical needs of patients suffering from heart conditions.

Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.

Reliable Med is a developer and provider of clinical mass spectrometry equipment designed for in vitro diagnostic (IVD) tests. The company focuses on addressing the needs of the medical industry by offering high-end clinical mass spectrometry devices and IVD detection kits. By doing so, Reliable Med aims to enhance the efficiency and accuracy of patient diagnoses within the healthcare sector.

Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

JenaValve Technology, Inc., established in 2006, specializes in developing and manufacturing transcatheter aortic valve replacement (TAVR) systems. Its flagship product, the Trilogy™ Heart Valve System, is designed to treat high-risk patients with symptomatic, severe aortic regurgitation and aortic stenosis. The system, which received CE Mark approval in 2021, features a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame with integral locators that engage with the native valve cusps. JenaValve operates globally, with headquarters in Irvine, California, and additional locations in Munich, Germany, and Leeds, United Kingdom.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.

Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.

New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.

Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, that specializes in developing innovative solutions for urology. Founded in 2014, the company focuses on its flagship product, Optilume, a drug-coated balloon (DCB) catheter designed to treat urethral strictures in men. This minimally invasive device combines balloon dilation with localized drug delivery, utilizing paclitaxel to prevent the recurrence of strictures by limiting cell proliferation and fibrotic scar tissue formation. Urotronic aims to provide urologists and patients with a cost-effective alternative to traditional treatment methods, improving outcomes for individuals suffering from urinary tract conditions.

Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its services encompass a range of clinical inspection instruments, including chemiluminescence and biochemical reagents, as well as technical support, management, and certification. Additionally, Chemclin operates independent medical laboratories and is focused on introducing innovative diagnostic products and services to the Chinese market.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Puyi Biotechnology operates in the high-value medical device sector, focusing on material science and drug delivery technology. The company specializes in developing minimally-invasive implanted devices, particularly degradable, drug-releasing sinus stents designed for use by healthcare professionals. These innovative stents improve patient outcomes following ear, nose, and throat surgeries. Additionally, Puyi Biotechnology extends its expertise to reproductive health and medical aesthetics, establishing a unique presence in these fields.

Yosemite Clinic is a multidisciplinary medical center located in Central Pudong, Shanghai, offering a wide range of walk-in services in a modern and well-equipped environment. The clinic provides specialties including family medicine, internal medicine, gynecology, pediatrics, rehabilitation, sports medicine, dentistry, ophthalmology, dermatology, and medical cosmetology. It is particularly noted for its focus on Minimally Invasive Surgery and Ambulatory Surgery. The facility is equipped with advanced medical imaging technology, including CT, X-ray, and ultrasound, alongside a fully operational laboratory and pharmacy. The clinic's diverse team of healthcare professionals hails from both China and around the world, allowing them to offer services in multiple languages such as English, Japanese, Malay, Mandarin Chinese, and Cantonese, ensuring comprehensive care for a diverse patient population.

Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.

Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

PhiSkin is a skin and laser clinic based in China, specializing in aesthetic medicine. The clinic offers a range of services, including aesthetic product injections such as Botox and hyaluronic acid, laser treatments, and non-surgical beauty procedures like double eyelid surgery. PhiSkin aims to provide customers with a comprehensive understanding of their skin conditions, along with tailored skincare solutions to meet individual needs.

Axonics Modulation Technologies, Inc. is a medical technology company focused on the development and commercialization of sacral neuromodulation (SNM) systems, catering to both domestic and international markets. The company’s SNM systems are designed to address conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. Its innovative rechargeable SNM System delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder and bowel to alleviate associated symptoms. Originally incorporated as American Restorative Medicine, Inc. in 2012, the company rebranded as Axonics Modulation Technologies, Inc. in August 2013 and is headquartered in Irvine, California.

Shanghai Neuromedical Center is a specialized clinic dedicated to the fields of functional neurosurgery, neurology, and neurorehabilitation. It offers comprehensive services including neurosurgery, brain tumor treatment, and epilepsy management, ensuring patients receive expert care tailored to their needs. The center integrates clinical practice with scientific research and education, emphasizing the importance of advancing knowledge in neurology and related disciplines. In addition to surgical interventions, the center also focuses on neuropsychology and emergency critical care medicine, reflecting a commitment to holistic patient care and rehabilitation.

DBSec is a reputable supplier of data security products, services, and solutions. They provide database encryption systems, database audit systems, cloud data security products, and holistic data security solutions. They serve the government, finance, social security, energy, military, operator, education, medical, and other industries.

New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.

Axonics Modulation Technologies, Inc. is a medical technology company focused on the development and commercialization of sacral neuromodulation (SNM) systems, catering to both domestic and international markets. The company’s SNM systems are designed to address conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. Its innovative rechargeable SNM System delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder and bowel to alleviate associated symptoms. Originally incorporated as American Restorative Medicine, Inc. in 2012, the company rebranded as Axonics Modulation Technologies, Inc. in August 2013 and is headquartered in Irvine, California.

Audoline is a hearing healthcare platform. They provide hearing medical services. They also provide a cochlear implant, a hearing aid, bone anchored hearing aids, and hearing accessories.

JenaValve Technology, Inc., established in 2006, specializes in developing and manufacturing transcatheter aortic valve replacement (TAVR) systems. Its flagship product, the Trilogy™ Heart Valve System, is designed to treat high-risk patients with symptomatic, severe aortic regurgitation and aortic stenosis. The system, which received CE Mark approval in 2021, features a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame with integral locators that engage with the native valve cusps. JenaValve operates globally, with headquarters in Irvine, California, and additional locations in Munich, Germany, and Leeds, United Kingdom.

MNCHIP specializes in the development and supply of in vitro diagnostic (IVD) equipment aimed at enhancing clinical decision-making and treatment pathways. The company offers a comprehensive range of products, including a chemistry analyzer and a PCR analyzer utilizing microfluidics technology. These devices enable healthcare professionals to deliver high-quality medical diagnostics at affordable prices, catering to patients across various income levels. MNCHIP is committed to innovation, regularly introducing new products to the market, with plans to release additional devices such as an immunoassay analyzer and a hematology analyzer in the near future. Through its efficient IVD tests, MNCHIP seeks to support the medical industry in improving patient outcomes while reducing overall healthcare costs.

LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

JenaValve Technology, Inc., established in 2006, specializes in developing and manufacturing transcatheter aortic valve replacement (TAVR) systems. Its flagship product, the Trilogy™ Heart Valve System, is designed to treat high-risk patients with symptomatic, severe aortic regurgitation and aortic stenosis. The system, which received CE Mark approval in 2021, features a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame with integral locators that engage with the native valve cusps. JenaValve operates globally, with headquarters in Irvine, California, and additional locations in Munich, Germany, and Leeds, United Kingdom.

Axonics Modulation Technologies, Inc. is a medical technology company focused on the development and commercialization of sacral neuromodulation (SNM) systems, catering to both domestic and international markets. The company’s SNM systems are designed to address conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. Its innovative rechargeable SNM System delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder and bowel to alleviate associated symptoms. Originally incorporated as American Restorative Medicine, Inc. in 2012, the company rebranded as Axonics Modulation Technologies, Inc. in August 2013 and is headquartered in Irvine, California.

Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.

Reach Surgical is a manufacturer of surgical instruments and medical equipment, established in 2005 as a foreign-owned enterprise in China. The company focuses on integrating research and development with production and sales, offering advanced solutions for minimally invasive surgeries. Its product range includes open series staplers and endoscopic staplers designed for thoracic and general surgery procedures. All products have received approvals from the US FDA and the EU CE, ensuring compliance with high industry standards. Reach Surgical operates three research and development centers located in Cincinnati, USA, and in Beijing and Shanghai, China, underscoring its commitment to innovation and improving surgical operation efficiency for clinical surgeons worldwide.

JenaValve Technology, Inc., established in 2006, specializes in developing and manufacturing transcatheter aortic valve replacement (TAVR) systems. Its flagship product, the Trilogy™ Heart Valve System, is designed to treat high-risk patients with symptomatic, severe aortic regurgitation and aortic stenosis. The system, which received CE Mark approval in 2021, features a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame with integral locators that engage with the native valve cusps. JenaValve operates globally, with headquarters in Irvine, California, and additional locations in Munich, Germany, and Leeds, United Kingdom.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

Bonovo Orthopedics, Inc. specializes in the development, manufacturing, distribution, and sale of orthopedic implants and related products for the Chinese healthcare market. Established in 2005 and headquartered in Scottsdale, Arizona, the company offers a diverse range of products, including artificial discs, spinal fixation systems, hip and knee joint replacements, and bone void fillers. Additionally, Bonovo provides minimally invasive surgical solutions, such as kyphoplasty systems for vertebral fractures, along with various surgical instruments and devices. With over 15 years of experience and strong partnerships with leading clinicians and hospitals, Bonovo is well-positioned to meet the demands of the Chinese orthopedic market. The company operates manufacturing facilities in Beijing and Shanghai, ensuring efficient production and distribution of its innovative orthopedic solutions.